Estimated Vaccination Coverage^ with Individual Vaccines and Vaccination Series Among Children 19-35 Months of Age by Race/Ethnicity* -- US, National Immunization Survey, Q3/2009-Q2/2010†
Vaccine US
National
White only,
non-Hispanic
Black only,
non-Hispanic
HispanicAmerican Indian or
Alaska Native only,
non-Hispanic
Asian only,
non-Hispanic
Native Hawaiian or Other Pacific Islander only,
non-Hispanic
Multiple Race,
non-Hispanic
3+DTaP¥95.0±0.695.5±0.794.1±1.794.2±1.795.8±3.895.8±2.897.8±2.696.1±1.7
4+DTaP‡84.1±1.085.0±1.280.1±2.883.8±2.583.9±6.687.9±4.4NA83.8±3.8
3+Polio§92.7±0.793.2±0.892.4±1.891.9±2.091.9±5.093.6±3.293.7±4.993.2±2.7
1+MMRll90.4±0.890.5±1.091.2±2.090.2±2.093.5±6.190.2±4.097.5±3.489.0±3.5
3+Hib¶86.2±1.086.2±1.284.5±2.587.5±2.289.3±5.284.9±5.3NA84.7±4.3
Hib-PS**91.6±0.892.1±1.089.8±2.191.7±1.992.1±4.889.7±4.594.0±5.592.2±2.7
Hib-FS††56.3±1.458.0±1.653.1±3.554.4±3.3NA58.8±7.8NA56.4±6.3
3+HepB‡‡92.1±0.791.8±0.992.5±1.792.4±1.894.3±4.291.6±3.795.4±4.592.3±2.9
Hep B Birth dose§§62.1±1.360.4±1.663.0±3.465.7±3.2NA58.1±8.5NA58.8±6.4
1+Varllll89.7±0.888.8±1.190.7±2.190.5±2.093.3±4.391.8±3.795.4±4.289.1±3.4
3+PCV¶¶92.7±0.793.3±0.892.1±1.992.3±2.094.0±4.288.8±4.298.0±2.592.6±2.9
4+PCV***81.4±1.183.1±1.275.7±3.082.1±2.580.9±6.976.2±8.2NA80.1±5.6
2+HepA†††48.7±1.446.0±1.646.0±3.554.4±3.2NA49.7±8.3NA50.0±6.4
Rotavirus‡‡‡53.1±1.454.5±1.645.8±3.554.2±3.3NA52.9±8.4NA51.2±6.4
4:3:1§§§81.6±1.182.5±1.278.1±3.081.1±2.682.7±6.885.6±4.7NA81.5±4.1
4:3:1:3llllll75.2±1.275.7±1.471.3±3.275.9±2.880.1±7.177.5±6.0NA73.5±5.1
4:3:1:3-PS¶¶¶79.4±1.180.5±1.375.4±3.179.0±2.781.1±6.981.0±5.6NA79.4±4.3
4:3:1:4-FS****52.3±1.454.1±1.648.2±3.550.4±3.3NA57.0±7.9NA52.3±6.3
4:3:1:3:3:1€71.5±1.270.9±1.568.9±3.373.6±2.977.6±7.674.0±6.3NA70.5±5.2
4:3:1:0:3:1ς77.5±1.177.2±1.475.2±3.178.3±2.780.1±7.381.8±5.2NA78.2±4.4
4:3:1:3:3:1-PS€€75.5±1.275.4±1.472.9±3.276.4±2.878.6±7.577.4±6.0NA76.4±4.5
4:3:1:4:3:1-FSςς50.0±1.451.0±1.646.7±3.548.8±3.3NA54.7±8.0NA49.9±6.3
4:3:1:3:3:1:4€€€66.1±1.366.2±1.561.6±3.468.5±3.071.4±8.561.1±8.3NA64.7±6.1
4:3:1:0:3:1:4ςςς71.5±1.272.0±1.467.1±3.372.9±2.873.2±8.366.6±8.3NA71.6±5.8
4:3:1:3:3:1:4-PS€€€€69.9±1.370.5±1.565.3±3.371.2±2.971.9±8.564.4±8.3NA70.3±5.8
4:3:1:4:3:1:4-FSςςςς47.1±1.448.6±1.643.2±3.446.1±3.3NA46.1±8.2NA47.9±6.4

 
^ Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.588 or (CI half width) >10.
Estimates presented as point estimate (%) ± 95% Confidence Interval.
* Self-reported by respondent. Children of Hispanic ethnicity may be of any race.
† Children in the Q3/2009-Q2/2010 National Immunization Survey were born from July 2006 through January 2009.
¥ 3 or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and any acellular pertussis vaccine (DTaP/DTP/DT).
‡ 4 or more doses of DTaP.
§ 3 or more doses of any poliovirus vaccine.
ll 1 or more doses of measles-mumps-rubella vaccine.
¶ 3 or more doses of Haemophilus influenzae type b (Hib) vaccine.
** Primary series Hib: ≥2 or ≥3 doses of Haemophilus influenzae type b (Hib), depending on brand type.
†† Full series Hib: ≥3 or ≥4 doses of Hib vaccine depending on product type received (includes primary series plus the booster dose).
‡‡ 3 or more doses of hepatitis B vaccine.
§§ 1 or more doses of hepatitis B vaccine administered between birth and age 3 days.
llll 1 or more doses of varicella at or after child's first birthday, unadjusted for history of varicella illness.
¶¶ 3 or more doses of pneumococcal conjugate vaccine (PCV).
*** 4 or more doses of PCV.
††† 2 or more doses of Hepatitis A vaccine.
‡‡‡ ≥2 or ≥3 doses of Rotavirus vaccine, depending on product type received (≥2 doses for Rotarix® [RVI] or ≥3 doses for RotaTeq® [RV5]).
§§§ 4 or more doses of DTaP, 3 or more doses of poliovirus vaccine, and 1 or more doses of any MMR vaccine.
llllll 4:3:1 plus 3 or more doses of Hib vaccine of any type.
¶¶¶ 4:3:1 plus the primary series Hib.
**** 4:3:1 plus the full series Hib.
€ 4:3:1 plus 3 or more doses of Hib vaccine of any type, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.
ς 4:3:1 plus 3 or more doses of HepB vaccine and 1 or more doses of varicella vaccine. Hib vaccine is excluded.
€€ 4:3:1 plus primary series of Hib vaccine, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.
ςς 4:3:1 plus full series of Hib vaccine, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.
€€€ 4:3:1 plus ≥3 doses of Hib vaccine of any type, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.
ςςς 4:3:1 plus 3 or more doses of HepB vaccine, 1 or more doses of varicella vaccine, and 4 or more doses of PCV. Hib vaccine is excluded.
€€€€ 4:3:1 plus primary series Hib vaccine, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.
ςςςς 4:3:1 plus full series Hib vaccine, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.
tab45_race_nat